The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Managing buffers in bioprocessing remains a largely manual process, requiring space and resources and often creating bottlenecks that increase costs and decrease efficiency. Researchers from many of ...

Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

BILLERICA, Mass.--(BUSINESS WIRE)--Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced a joint partnership with Boston BioProducts, a cGMP ...

We listened to our customers’ frustrations with the complex process of centralized GMP liquid media manufacturing. With the Krakatoa® K500, we begin a journey to co-locate both media and buffer ...

Discover how alternative buffer management strategies can reduce footprint, cut costs, and streamline downstream bioprocessing. Explore practical approaches, like buffer concentrates and stock ...

Framing media/buffer risk around lead time, consistency, and expiry aligns raw-material controls with clinical urgency and unpredictable consumption patterns. On-site manufacture can reduce ...

The "Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of ...

NB-Lux™ AI connects formulation through GMP manufacturing in a single AI-enabled ecosystem, accelerating timelines and improving transparency from R&D through Excipient GMP. Built off NB-Lux™, the ...